Gene Therapy for Sickle Cell Disease

The high-risk price of these therapies is vast in excess of two million pounds often. But you do have to offset that with the costs of long-term chronic disease, which these patients would otherwise have. It's a massive challenge that we're facing at the moment and we really need to find new ways to ensure that patients in need can access these therapies. Many people have looked into innovative reimbursement strategies and payment strategies for these high-cost therapies.